Nowak-Choi Kamila, Palmer Joshua D, Casey James, Chitale Ameet, Kalchman Ingrid, Buss Elizabeth, Keith Scott W, Hegarty Sarah E, Curtis Mark, Solomides Charalambos, Shi Wenyin, Judy Kevin, Andrews David W, Farrell Christopher, Werner-Wasik Maria
Department of Radiation Oncology, Medstar Franklin Square Hospital, Baltimore, MD, USA.
Department of Radiation Oncology and Department of Neurosurgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.
J Neurooncol. 2021 Mar;152(1):145-151. doi: 10.1007/s11060-020-03688-1. Epub 2021 Jan 9.
Despite optimal surgical resection, meningiomas may recur, with increasing grade and the degree of resection being predictive of risk. We hypothesize that an increasing Ki67 correlates with a higher risk of recurrence of resected WHO grade I meningiomas.
The study population consisted of patients with resected WHO grade 1 meningiomas in locations outside of the base of skull. Digitally scanned slides stained for Ki67 were analyzed using automatic image analysis software in a standardized fashion.
Recurrence was observed in 53 (17.7%) of cases with a median follow up time of 25.8 months. Ki67 ranged from 0 to 30%. Median Ki67 was 5.1% for patients with recurrence and 3.5% for patients without recurrence. In unadjusted analyses, high Ki-67 (≥ 5 vs. < 5) vs. ≥ 5) was associated with over a twofold increased risk of recurrence (13.1% vs. 27% respectively; HR 2.1731; 95% CI [1.2534, 3.764]; p = 0.006). After Adjusting for patient or tumor characteristics, elevated Ki-67 remained significantly correlated with recurrence. Grade 4 Simpson resection was noted in 71 (23.7%) of patients and it was associated with a significantly increased risk of recurrence (HR 2.56; 95% CI [1.41, 4.6364]; p = 0.002).
WHO grade 1 meningiomas exhibit a significant rate of recurrence following resection. While Ki-67 is not part of the WHO grading criteria of meningiomas, a value greater than 5% is an independent predictor for increased risk of local recurrence following surgical resection.
尽管进行了最佳手术切除,脑膜瘤仍可能复发,分级增加和切除程度可预测复发风险。我们假设,Ki67升高与世界卫生组织(WHO)I级脑膜瘤切除术后复发风险较高相关。
研究人群包括颅底以外部位的WHO 1级脑膜瘤切除术患者。使用自动图像分析软件以标准化方式分析经Ki67染色的数字扫描玻片。
53例(17.7%)出现复发,中位随访时间为25.8个月。Ki67范围为0至30%。复发患者的Ki67中位数为5.1%,未复发患者为3.5%。在未校正分析中,高Ki-67(≥5% vs. <5%)与复发风险增加两倍以上相关(分别为13.1%和27%;风险比2.1731;95%置信区间[1.2534, 3.764];p = 0.006)。在对患者或肿瘤特征进行校正后,Ki-67升高仍与复发显著相关。71例(23.7%)患者进行了4级Simpson切除,其与复发风险显著增加相关(风险比2.56;95%置信区间[1.41, 4.6364];p = 0.002)。
WHO 1级脑膜瘤切除术后复发率较高。虽然Ki-67并非WHO脑膜瘤分级标准的一部分,但大于5%的值是手术切除后局部复发风险增加的独立预测指标。